Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Inhibition of the immunoproteasome ameliorates experimental autoimmune encephalomyelitis.
Reduction in the free radical status and clinical benefit of repeated intrathecal triamcinolone acetonide application in patients with progressive multiple sclerosis.
Anti Mycobacterium avium subsp. paratuberculosis heat shock protein 70 antibodies in the sera of Sardinian patients with multiple sclerosis.
Multicystic demyelinating myelopathy: Widening spectrum of pediatric aquaporin-4 autoimmunity.
Relapsing inappropriate antidiuretic hormone secretion in an anti-aquaporin-4 antibody positive paediatric patient.
Clinically isolated syndrome manifested as acute vestibular syndrome: Bedside neuro-otological examination and suppression of transient evoked otoacoustic emissions in the differential diagnosis.
Neuroinflammatory changes negatively impact on LTP: A focus on IL-1β
Dietary interventions for multiple sclerosis.
Interleukin-12p40 in the spinal fluid as a biomarker for clinically isolated syndrome.
Redox processes in neurodegenerative disease involving reactive oxygen species.
Neurofascin-155 IgG4 in chronic inflammatory demyelinating polyneuropathy.
Progressive Injury in Chronic Multiple Sclerosis Lesions Is Gender-Specific: A DTI Study.
The oncoprotein and transcriptional regulator bcl-3 governs plasticity and pathogenicity of autoimmune T cells.
Suppression of Th1-mediated autoimmunity by embryonic stem cell-derived dendritic cells.
Biological monitoring of IFN-β therapy in Multiple Sclerosis.
Core muscle strength and endurance measures in ambulatory persons with multiple sclerosis: validity and reliability.
Microglia: Multitasking Specialists of the Brain.
The Neural Stem Cell Microenvironment: Focusing on Axon Guidance Molecules and Myelin-Associated Factors.
Improving communication with multiple sclerosis patients.
Susceptibility-weighted imaging in the experimental autoimmune encephalomyelitis model of multiple sclerosis indicates elevated deoxyhemoglobin, iron deposition and demyelination.
William Austin Sibley, MD (1925-2015).
Layered genetic control of DNA methylation and gene expression: a locus of multiple sclerosis in healthy individuals.
Integrated transcriptomic-proteomic analysis using a proteogenomic workflow refines rat genome annotation.
Myelin morphology and axon pathology in demyelination during experimental autoimmune encephalomyelitis.
Combined therapy with methylprednisolone and ulinastatin in experimental autoimmune encephalomyelitis.
Pages
« first
‹ previous
…
459
460
461
462
463
464
465
466
467
…
next ›
last »